Amylyx Pharmaceuticals (NASDAQ:AMLX) Price Target Cut to $3.00 : vimarsana.com

Amylyx Pharmaceuticals (NASDAQ:AMLX – Free Report) had its price target decreased by Mizuho from $4.00 to $3.00 in a report issued on Tuesday, Benzinga reports. Mizuho currently has a neutral rating on the stock. A number of other research firms have also recently weighed in on AMLX. HC Wainwright reaffirmed a buy rating and issued […]

Related Keywords

United States , Arizona , China , Canada , Leerink Partnrs , Robertw Baird , Zurcher Kantonalbank Zurich Cantonalbank , Gina Mazzariello , Joshuab Cohen , China Universal Asset Management Co , Quest Partners , Amylyx Pharmaceuticals Stock Performance , Insider Transactions At Amylyx Pharmaceuticals , Allspring Global Investments Holdings , News Ratings For Amylyx Pharmaceuticals Daily , Amylyx Pharmaceuticals Inc , Institutional Trading Of Amylyx Pharmaceuticals , Analyst Recommendations For Amylyx Pharmaceuticals , Amylyx Pharmaceuticals , Free Report , Get Free Report , Universal Asset Management , Global Investments Holdings , Kantonalbank Zurich Cantonalbank , Arizona State Retirement System , Amylyx Pharmaceuticals Daily ,